Background The lipoprotein system has manifold links to atherosclerotic disease. LDL cholesterol is related to lesion formation and growth. The cholesterol of HDLs is indicative of protection against atherosclerosis. The status of triglycerides and of subfractions of high-density lipoproteins as risk factors is less certain. Also, the magnitude of the atherogenic/protective power of these factors is not known.
T he plasma concentrations of cholesterol and of its main component, LDL cholesterol, are established risk factors for the incidence of atherosclerotic vascular complications. 12 Epidemiological studies have also consistently demonstrated that plasma concentrations of HDL cholesterol are inversely correlated with the incidence of coronary artery disease (CAD). [3] [4] [5] [6] Animal data suggest that this is a causal association: In transgenic mice, overexpression of the apolipoprotein A-I gene increased plasma HDL cholesterol and inhibited the development of early atherosclerotic ("fatty streak") lesions,7 and infusion of HDL induced regression of established fatty streaks in rabbits. 8 Human HDL is a heterogeneous mixture of lipoprotein particles comprising two principal subfractions, HDL2 and HDL,.9 A widely held view is that the benefit of HDL is linked to HDL2.1'0-However, recent data from a case-control study12 and from the prospective Physicians' Health Study13 suggest that HDL3 confers equal if not superior protection against myocardial infarction.
A long-standing debate is to what extent triglycerides contribute to the risk of atherosclerosis. In cross-sectional studies, triglycerides show a univariate association with coronary artery disease, and this association persists after cholesterol or LDL cholesterol is taken into account.14 However, in prospective studies controlling also for HDL cholesterol concentration, triglycerides are eliminated as an independent risk factor in most studies. 14 Myocardial infarction may be a suboptimal end point to assess atherogenicity because it represents the last step in a series of events triggered by atherogenic and thrombogenic factors; thrombogenic factors ultimately determine whether or not infarction occurs.15'6 Therefore, the incidence of myocardial infarctions is related to both thrombogenicity and atherosclerosis. Angiography preferentially assesses atherosclerosis. A relation of LDL cholesterol to angiographic characteristics of coronary atherosclerosis is well established. '7-20 The few angiographic studies on HDL subfractions that have been published indicate a strong correlation between coronary atherosclerosis and decreased HDL2 levels, LDL cholesterol and the two subfractions of HDL cholesterol has not been assessed by angiography. We therefore studied the independent relations of LDL cholesterol, HDL2 cholesterol, HDL3 cholesterol, and triglycerides to the presence and extent of coronary atherosclerosis in 500 patients who had angiography with a total of more than 1000 coronary lesions.
Methods

Patient Selection
The study group comprised consecutive patients undergoing elective coronary angiography for evaluation of established or suspected CAD. Indications for angiography were exerciseinduced stable angina, silent ischemia, previous myocardial infarction, atypical chest pain, aortic stenosis, aortic regurgitation, and mitral regurgitation. Only 
Results
Of the 500 patients enrolled in the study, 56 were excluded from analysis because they were taking lipidlowering drugs. Of the remaining 444 subjects, 339 had one or more significant (.50%) coronary lesions (CAD+); 105 were free of such lesions (CAD-). In contrast to these problems with measurement of true LDL cholesterol, the two main subfractions of HDL cholesterol can be readily separated in the clinical laboratory. While the predictive power of HDL for the development of coronary atherosclerosis is well documented, it is less clear which of its subfractions is involved. We found that only HDL2 is significantly related to the presence of coronary atherosclerosis but that both HDL2 and HDL3 are significantly predictive of disease extent.
These data clarify some of the controversy in the literature regarding the relation of HDL subfractions to CAD. Published studies differed by definition of CAD and by results: CAD presence was documented by myocardial infarction in prospective13'34'35 and retrospective studies12'36 and by angiographic evidence. 22 Presence of CAD was inconsistently related to HDL subfractions, with one study demonstrating relations solely of HDL235 and others more of HDL2 than of HDL3,22,34 more of HDL3 than of HDL2,13,36 or equally of HDL2 and HDL3.12 However, those studies had one important limitation: none proved absence of significant CAD by angiography of control subjects. Thus, clinically silent but significant CAD may have been present in control subjects. In addition, in one study,'3 only nonfasting plasma samples were available, and it has been argued37 that the postprandial state probably affected HDL subfraction distribution. In contrast to these previous studies, we demonstrated the absence of significant CAD angiographically in all individuals of the comparison group and used fasting plasma samples. We detected the larger difference (between the patients and the comparison group) in HDL2 cholesterol (>30%) than in HDL3 cholesterol (=10%). These differences were remarkably similar to those reported in the prospective study by Gofman et al,34 in which patients with CAD had 32% lower HDL2 and 8% lower HDL3 levels than control subjects.
The relation of HDL subfractions to the extent of CAD has been addressed in two studies.21,36 Brook et a136 found no relation in 10 patients, whereas Miller et a121 demonstrated a significant association with HDL2 (but not of HDL3) in 104 patients. We found a significant association with CAD extent of both HDL2 and HDL3 cholesterol. Obviously, a large sample size is necessary to reveal the contributions of the two subfractions to CAD extent.
The mechanism by which HDL protects against atheroma is not fully understood. One concept is reversed cholesterol transport. Free cholesterol leaving cells is transferred to the surface of small so-called pre-P-HDL, where it is esterified to intensively hydrophobic cholesterol esters by lecithin:cholesterol acyl transferase to form a central lipid droplet. The levels of HDL cholesterol and particularly of the more cholesterol-enriched HDL2 thus reflect the activity of this transport system. An alternative idea is that HDL impedes the oxidative modification of LDL3839 that is believed necessary for its uptake into the arterial wall. 40 Such HDL particles could hence protect from atherosclerosis by interfering with the atherogenicity of LDL.
Apart from age, sex, and cholesterol subfractions, triglycerides emerged as a significant and independent predictor for the extent of coronary atherosclerosis. It fits well into this notion that hypertriglyceridemia is frequently encountered in diabetic patients,14 in whom extent of coronary atherosclerosis is greater than in nondiabetic patients,4142 and is related to triglyceride levels.41 However, a very sensitive tool is required to prove this association of triglycerides with disease extent also for nondiabetics who have a lower prevalence of hypertriglyceridemia. This is also demonstrated by our data: Triglycerides were not related to the less sensitive end point, presence of coronary atherosclerosis. From the three published angiographic studies in which triglyceride levels were adjusted for HDL cholesterol, the triglyceride association with disease extent remained significant in two43"44 but did not in one. 45 However, none of them studied HDL subfraction cholesterol together with triglycerides.
Because of the correlation between HDL cholesterol and triglycerides, in most studies, triglycerides are eliminated as an independent risk factor when HDL cholesterol is included in multiple logistic regression models. ' 50 These numbers compare well to our risk ratios.
In summary, this large angiographic study demonstrates that a number of critical steps in lipid metabolism that have been recently elucidated are operative in vivo and contribute importantly to the extent of coronary atherosclerosis. Angiographic studies, however, have some limitations that can be dissected into three problem areas51: First, inclusion of patients who recently had a myocardial infarction may alter risk factor levels. This problem was circumvented in our study in that patients who had an infarction within the previous 12 weeks were excluded from the study. Moreover, risk factors may be related to other causes of infarction than atherosclerosis, such as the clotting system or spasm. This limitation does not apply to our study because infarction per se was not an end point, and patients with old infarctions were classified simply according to their lesion number. The second problem area is that control subjects are not necessarily free of atherosclerosis. However, of our 105 subjects of the comparison group, only 12 had 30% to 50% stenoses, and 75 had none at all. Since absence of significant lesions was shown in all individuals of the comparison group and only a few patients with nonsignificant lesions were included, our comparison group appears better defined than "control subjects" defined simply by absence of clinical end points. A third concern is that arteriography series may have inherent selection bias because hyperlipidemic patients may be more readily referred to angiography than normolipidemic subjects. This was not the case in our cohort, because all referrals were based on clinical criteria and lipids were never considered for referral. Also, no acute coronary syndromes or disease states that alter lipid values were included. Thus, none of these three principal concerns substantially limited the validity of our data.
